NLTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.58%

Insider Buying (Last 12 Months): $1,305,132.60

Insider Selling (Last 12 Months): $818.40

Neoleukin Therapeutics Insider Trading History Chart

Neoleukin Therapeutics Share Price & Price History

^$44.83

▲ +2.13 (4.99%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

The next companies to potentially benefit thanks to Nvidia are …

From Weiss Ratings | Ad

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

Neoleukin Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/17/2023	Bros. Advisors Lp Baker	Director	Buy	8,347	$13.80	$115,188.60	280,647
8/15/2023	Bros. Advisors Lp Baker	Director	Buy	94,440	$12.60	$1,189,944.00	262,330
8/11/2023	Sean Michael Smith	CFO	Sell	66	$12.40	$818.40	1,081
4/3/2023	Priti Patel	Insider	Sell	188	$13.80	$2,594.40	1,865
8/10/2022	Sean Michael Smith	Insider	Sell	82	$19.80	$1,623.60	338
5/2/2022	Priti Patel	Insider	Sell	276	$24.40	$6,734.40	323
8/24/2021	Jonathan G. Drachman	CEO	Buy	5,000	$122.20	$611,000.00	117,434

Collapse of the Petrodollar

From Colonial Metals | Ad

The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.

In answer to this issue, we have released a Special Report to the public.

SEC Filings (Institutional Ownership Changes) for Neoleukin Therapeutics (NASDAQ:NLTX)

52.37% of Neoleukin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neoleukin Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Redmile Group LLC	582,443	$2.30M	0.1%	-80.0%	6.619%
11/15/2023	Kynam Capital Management LP	24,037	$95K	0.0%	-80.0%	0.273%
11/15/2023	Adage Capital Partners GP L.L.C.	310,000	$1.22M	0.0%	N/A	3.523%
10/23/2023	BML Capital Management LLC	98,664	$0.39M	0.4%	+315.4%	1.121%
7/26/2023	Privium Fund Management B.V.	117,200	$95K	0.0%	N/A	0.274%
5/15/2023	MYDA Advisors LLC	40,000	$28K	0.0%	N/A	0.093%
5/9/2023	US Bancorp DE	44,346	$31K	0.0%	+111.2%	0.104%
11/14/2022	Point72 Asset Management L.P.	2,064,222	$1.32M	0.0%	+43.6%	4.848%
11/1/2022	Privium Fund Management UK Ltd	117,200	$75K	0.1%	N/A	0.275%
8/15/2022	Opaleye Management Inc.	610,000	$0.63M	0.3%	-22.8%	1.433%
8/9/2022	Pictet Asset Management SA	781,551	$0.81M	0.0%	-69.6%	1.839%
8/8/2022	Simon Quick Advisors LLC	46,856	$49K	0.0%	N/A	0.110%
7/27/2022	Bailard Inc.	90,100	$93K	0.0%	N/A	0.212%
7/14/2022	Adviser Investments LLC	65,404	$67K	0.0%	+39.7%	0.154%
5/12/2022	Gyon Technologies Capital Management LP	36,803	$69K	0.0%	N/A	0.087%
5/11/2022	ACT Capital Management LLC	199,000	$0.37M	0.4%	-6.4%	0.468%
5/4/2022	Adviser Investments LLC	46,817	$88K	0.0%	+347.6%	0.110%
5/2/2022	Allspring Global Investments Holdings LLC	45,709	$85K	0.0%	N/A	0.108%
2/14/2022	PDT Partners LLC	39,462	$0.19M	0.0%	+90.0%	0.093%
2/14/2022	Redmile Group LLC	3,490,835	$16.83M	0.4%	-0.5%	8.228%
2/14/2022	Point72 Asset Management L.P.	1,010,790	$4.87M	0.0%	+1.1%	2.382%
2/14/2022	GSA Capital Partners LLP	130,899	$0.63M	0.1%	+73.6%	0.309%
2/11/2022	Renaissance Technologies LLC	843,612	$4.07M	0.0%	+11.5%	1.988%
2/10/2022	Pictet Asset Management SA	2,574,289	$12.41M	0.0%	-3.4%	6.067%
2/10/2022	Acadian Asset Management LLC	23,405	$0.11M	0.0%	N/A	0.055%
2/8/2022	Northern Trust Corp	326,497	$1.57M	0.0%	-7.1%	0.770%
2/3/2022	Los Angeles Capital Management LLC	51,453	$0.25M	0.0%	+20.7%	0.121%
2/3/2022	ACT Capital Management LLC	212,500	$1.02M	0.7%	-11.1%	0.501%
2/2/2022	New York State Common Retirement Fund	14,396	$69K	0.0%	-57.2%	0.034%
1/31/2022	Adviser Investments LLC	10,460	$50K	0.0%	N/A	0.025%
1/21/2022	Kestra Private Wealth Services LLC	12,000	$58K	0.0%	N/A	0.028%
1/21/2022	Pinnacle Wealth Planning Services Inc.	14,303	$69K	0.0%	N/A	0.034%
11/22/2021	EcoR1 Capital LLC	860,619	$6.22M	0.2%	-63.5%	2.028%
11/16/2021	Opaleye Management Inc.	1,047,300	$7.57M	1.4%	-9.4%	2.468%
11/16/2021	Two Sigma Advisers LP	174,600	$1.26M	0.0%	+192.5%	0.412%
11/16/2021	Two Sigma Investments LP	120,212	$0.87M	0.0%	+207.5%	0.283%
11/16/2021	Metropolitan Life Insurance Co NY	4,698	$34K	0.0%	-52.4%	0.011%
11/15/2021	Point72 Asset Management L.P.	1,000,000	$7.23M	0.0%	+13.2%	2.357%
11/15/2021	Marshall Wace LLP	19,421	$0.14M	0.0%	N/A	0.046%
11/15/2021	Granahan Investment Management Inc. MA	125,331	$0.91M	0.0%	-35.8%	0.295%
11/15/2021	GSA Capital Partners LLP	75,419	$0.55M	0.1%	N/A	0.178%
11/12/2021	Trexquant Investment LP	34,300	$0.25M	0.0%	+141.4%	0.081%
11/12/2021	Renaissance Technologies LLC	756,892	$5.47M	0.0%	+31.4%	1.784%
11/12/2021	Macquarie Group Ltd.	11,960	$86K	0.0%	+2,208.9%	0.028%
11/12/2021	The Manufacturers Life Insurance Company	11,580	$84K	0.0%	-45.8%	0.027%
11/12/2021	Geode Capital Management LLC	617,827	$4.47M	0.0%	+6.0%	1.456%
11/10/2021	Goldman Sachs Group Inc.	117,656	$0.85M	0.0%	-43.6%	0.277%
11/10/2021	Citigroup Inc.	6,773	$49K	0.0%	-88.6%	0.016%
11/9/2021	BlackRock Inc.	2,669,276	$19.30M	0.0%	+1.2%	6.291%
11/9/2021	Candriam Luxembourg S.C.A.	858,173	$6.20M	0.0%	+67.6%	2.023%
11/8/2021	Los Angeles Capital Management LLC	42,633	$0.31M	0.0%	-8.0%	0.100%
11/2/2021	New York State Common Retirement Fund	33,672	$0.24M	0.0%	-27.9%	0.079%
11/1/2021	SG Americas Securities LLC	22,340	$0.16M	0.0%	N/A	0.053%
8/17/2021	Metropolitan Life Insurance Co NY	9,870	$91K	0.0%	+98,600.0%	0.023%
8/17/2021	Millennium Management LLC	157,971	$1.46M	0.0%	+7.9%	0.372%
8/17/2021	MetLife Investment Management LLC	14,552	$0.13M	0.0%	+281.3%	0.034%
8/17/2021	Price T Rowe Associates Inc. MD	35,534	$0.33M	0.0%	+16.1%	0.084%
8/16/2021	Bank of America Corp DE	184,214	$1.70M	0.0%	+481.9%	0.434%
8/16/2021	UBS Asset Management Americas Inc.	10,340	$95K	0.0%	N/A	0.024%
8/16/2021	Point72 Asset Management L.P.	883,102	$8.15M	0.0%	-32.5%	2.082%
8/16/2021	Cubist Systematic Strategies LLC	5,499	$51K	0.0%	+399.9%	0.013%
8/16/2021	Opaleye Management Inc.	1,156,200	$10.67M	1.8%	-5.6%	2.725%
8/16/2021	Redmile Group LLC	3,919,235	$36.18M	0.5%	-4.8%	9.238%
8/16/2021	Morgan Stanley	631,008	$5.82M	0.0%	+82.5%	1.487%
8/16/2021	Charles Schwab Investment Management Inc.	88,594	$0.82M	0.0%	+7.3%	0.209%
8/16/2021	State Street Corp	1,235,098	$11.40M	0.0%	-21.8%	2.911%
8/16/2021	Goldman Sachs Group Inc.	208,717	$1.93M	0.0%	-38.3%	0.492%
8/13/2021	Renaissance Technologies LLC	575,992	$5.32M	0.0%	-6.8%	1.358%
8/13/2021	Northern Trust Corp	364,492	$3.36M	0.0%	-2.5%	0.859%
8/13/2021	Qube Research & Technologies Ltd	16,385	$0.15M	0.0%	N/A	0.039%
8/13/2021	Geode Capital Management LLC	582,625	$5.38M	0.0%	+8.4%	1.373%
8/13/2021	Vanguard Group Inc.	1,593,582	$14.71M	0.0%	+5.0%	3.756%
8/13/2021	ProShare Advisors LLC	16,743	$0.16M	0.0%	+16.2%	0.039%
8/12/2021	Trexquant Investment LP	14,211	$0.13M	0.0%	N/A	0.033%
8/12/2021	Dimensional Fund Advisors LP	37,145	$0.34M	0.0%	+153.4%	0.088%
8/12/2021	JPMorgan Chase & Co.	16,267	$0.15M	0.0%	+33.9%	0.038%
8/12/2021	The Manufacturers Life Insurance Company	21,349	$0.20M	0.0%	+12.2%	0.050%
8/11/2021	BlackRock Inc.	2,638,758	$24.36M	0.0%	-2.6%	6.220%
8/10/2021	State Board of Administration of Florida Retirement System	19,092	$0.18M	0.0%	+19.5%	0.045%
8/10/2021	Citigroup Inc.	59,211	$0.55M	0.0%	-32.7%	0.140%
8/10/2021	Rafferty Asset Management LLC	36,258	$0.34M	0.0%	-48.1%	0.086%
8/6/2021	Swiss National Bank	73,900	$0.68M	0.0%	+11.8%	0.175%
8/5/2021	Rhumbline Advisers	50,457	$0.47M	0.0%	+43.3%	0.119%
8/5/2021	Los Angeles Capital Management LLC	46,363	$0.43M	0.0%	+69.2%	0.109%
8/2/2021	New York State Common Retirement Fund	46,677	$0.43M	0.0%	-9.5%	0.110%
7/31/2021	Personal CFO Solutions LLC	23,710	$0.22M	0.0%	+26.7%	0.056%
7/30/2021	Alliancebernstein L.P.	26,400	$0.24M	0.0%	+18.9%	0.062%
5/18/2021	Millennium Management LLC	146,349	$1.80M	0.0%	+2.4%	0.346%
5/18/2021	Opaleye Management Inc.	1,225,000	$15.08M	2.2%	-11.6%	2.893%
5/18/2021	Point72 Asset Management L.P.	1,308,600	$16.11M	0.1%	+9.4%	3.090%
5/18/2021	Morgan Stanley	345,671	$4.26M	0.0%	-19.7%	0.816%
5/18/2021	Redmile Group LLC	4,117,569	$50.69M	0.7%	-0.3%	9.724%
5/17/2021	Royal Bank of Canada	9,483	$0.12M	0.0%	+14.6%	0.022%
5/17/2021	Price T Rowe Associates Inc. MD	30,594	$0.38M	0.0%	+52.4%	0.072%
5/17/2021	Ameriprise Financial Inc.	14,190	$0.18M	0.0%	N/A	0.034%
5/17/2021	Nuveen Asset Management LLC	141,881	$1.75M	0.0%	-52.8%	0.335%
5/17/2021	Goldman Sachs Group Inc.	338,530	$4.17M	0.0%	+1,091.0%	0.799%
5/14/2021	Dimensional Fund Advisors LP	14,658	$0.18M	0.0%	-94.0%	0.035%
5/14/2021	Credit Suisse AG	17,612	$0.22M	0.0%	-58.2%	0.042%
5/13/2021	Renaissance Technologies LLC	617,937	$7.61M	0.0%	-19.0%	1.460%

Data available starting January 2016

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Today's Range

Now: $44.83

$42.46

$45.13

50 Day Range

MA: $37.20

$30.32

$45.75

52 Week Range

Now: $44.83

$2.03

$14.36

Volume

185,721 shs

Average Volume

50,104 shs

Market Capitalization

$421.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the company insiders with the largest holdings of Neoleukin Therapeutics?: Neoleukin Therapeutics' top insider investors include:
Bros Advisors Lp Baker (Director)
Priti Patel (Insider)
Sean Michael Smith (CFO)
Sean Michael Smith (Insider)
Learn More about top insider investors at Neoleukin Therapeutics.